Predicting Antigen-Specific T Cell Immunity Against Wilms Tumor 1 in Hematologic Cancer
Wilms tumor 1 (WT1) is a tumor-associated antigen expressed in both solid tumors and hematological cancers. In myeloid malignancies, such as acute myeloid leukemia (AML), chronic myeloid leukemia (CML), and myelodysplastic syndrome (MDS), WT1 is overexpressed and relates to worse prognosis. Clinical...
Saved in:
Published in | Blood Vol. 144; no. Supplement 1; p. 3596 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
05.11.2024
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!